MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain.
Mutations in the gene encoding the methyl-CG binding protein MeCP2 cause several neurological disorders including Rett syndrome. The di-nucleotide methyl-CG (mCG) is the classical MeCP2 DNA recognition sequence, but additional methylated sequence targets have been reported. Here we show by in vitro...
Main Authors: | Sabine Lagger, John C Connelly, Gabriele Schweikert, Shaun Webb, Jim Selfridge, Bernard H Ramsahoye, Miao Yu, Chuan He, Guido Sanguinetti, Lawrence C Sowers, Malcolm D Walkinshaw, Adrian Bird |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-05-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC5446194?pdf=render |
Similar Items
-
Reassessment of Viroid RNA Cytosine Methylation Status at the Single Nucleotide Level
by: Francesco Di Serio, et al.
Published: (2019-04-01) -
Quantitative analysis questions the role of MeCP2 as a global regulator of alternative splicing.
by: Kashyap Chhatbar, et al.
Published: (2020-10-01) -
Recognizing Cancer-related Genes based on Single Nucleotide Polymorphisms
by: Y.C. Wang, et al.
Published: (2005) -
MeCP2 and Chromatin Compartmentalization
by: Annika Schmidt, et al.
Published: (2020-04-01) -
Biochemical analysis of MeCP2
by: Klose, Robert John
Published: (2005)